Two fair-quality trials of gabapentin (Neurontin) reported significantly reduced hot-flash frequency compared Alternative to paxil with placebo. (19) Furthermore, since it is thought to act similarly to estrogen in some ways in the body, it is usually not recommended for women for whom estrogen is not recommended. Food and Drug Administration has determined that Apotex' paroxetine tablets are therapeutically equivalent to Alternative to paxil glaxosmithkline's (GSK) Paxil(R). Two reviewers independently rated the quality of trials; disagreements were resolved by consensus agreement with a third reviewer. Systematic review and meta-analysis. (15,21) There is also some evidence that hypnosis may help reduce the frequency, duration and severity of hot flashes. The first well-controlled trial of vitamin E, conducted in 1953, found it was no more effective than a placebo in relieving menopausal symptoms, but a trial in women with breast cancer conducted in 1998 found it did relieve hot flashes. Patients whose alternative to paxil initial response was insufficient could increase the dose of hypericum extract to 1,800 mg/day or of paroxetine to 40 mg/day. Alternative to paxil john's wort or sertraline, he said. In the German study, patients were limited to only one previous alternative to paxil adequate antidepressant therapy trial, "probably limiting the number of treatment-resistant patients," he said. Alternative to paxil these investigators thoroughly searched Medline, The Cochrane Registry, other large databases, reference lists of recent systematic reviews and relevant articles, and they consulted experts. "Sertraline, a proven alternative to paxil synthetic antidepressant, served as a positive control to check the sensitivity of the study. Paroxetine hydrochloride alternative to paxil is the active ingredient in Paxil(R).
These products should not be used for this purpose until more is known from long-term clinical trials about ideal alternative to paxil therapeutic doses. Although HRT effectively controls hot flashes, recent research documenting its long-term dangers have made many women leery of using it. In a study funded by GlaxoSmithKline, Paxil's manufacturer, 165 menopausal women took Paxil (in either a low or moderate dose) or a placebo for 6 weeks and kept a daily diary of their hot flashes. Clinically and statistically significant reductions in daily hot flash composite scores were noted within 1 week in both paroxetine groups, and more than 60% of patients in the paroxetine groups had at least a 50% reduction in hot flash frequency and severity by week 6. Klement of Schwabe Pharmaceuticals.
"This is further affirmation," continued Dr.